markie 125. : you DD is very poor ...The big market for Atl1102 is that it works in Conjunction with other drugs..
Sarepta has to prove to the FDA that their drug for 13% of the DMD boys is meaningful so they will be the first to use Atl1102...
Now : think of all the other drugs where inflammation is a nuisance Asthma, Spms, etc
$$$$ “in conjunction with “ Worldwide we have the only inflammation drug that works $$$$$$$$
Sarepta eyes multiple sclerosis gene therapy, page-31
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
